The PI3K/Akt/mTOR pathway is found deregulated in cancer, which is characterized by an overexpression/hyperactivation of its effector proteins and alterations in the genes that encode those proteins (Revathidevi and Munirajan, 2019). The gene discussed is AKT1; the disease is cancer.